Despite RBS reporting a jump in annual profits this morning, investors are unimpressed and have sent shares in the bank down 5% in early trade.
That makes RBS the biggest faller in the FTSE 100 this morning, with the index itself down 30.67 points at 7,421.36.
Drugmaker AstraZeneca was also a big faller, down 4.4%, after its fourth quarter results fell short of expectations.
The company reported quarterly product sales of $6.25bn, below analysts’ forecasts of $6.31bn.
The mid-cap FTSE 250 index is up 48.80 points at 21,722.70.